DRKS00033107招募中不适用
Role of Bile Acids in the Pathogenesis of Cirrhotic Cardiomyopathy - Bile Acids CCM
Klinik für Kardiologie, Pneumologie und Angiologie0 个研究点目标入组 1,000 人开始时间: 2023年11月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •Male, female, diverse patients from the Clinic for Cardiology, Pneumology and Angiology who receive an echocardiographic examination for clinical reasons, with and without existing liver disease
- •- Male, female, various patients from the Clinic for Cardiology, Pneumology and Angiology who receive an echocardiographic examination for clinical reasons with existing liver disease with indication for TIPPS or liver transplantation.
- •- Persons who are able to understand and follow the instructions of the study personnel
- •- Written informed consent
排除标准
- •- Age < 18 years
- •- Lack of written consent to participate in the study
研究者
相似试验
已完成
不适用
The physiological role of bile acid*mediated glucagon*like peptide*1 release in humans: the Cerebrotendinous Xanthomatosis Mixed Meal Test studybile acid synthesis defect1002742410018424NL-OMON36008Academisch Medisch Centrum28
尚未招募
不适用
The physiological role of bile acid‐mediated glucagon‐like peptide‐1 release in humans: The Cerebrotendinous Xanthomatosis Mixed Meal Test study.NL-OMON23193AMC28
招募中
不适用
Bile acid sequestrants in non-healing Barrett's esophagus after endoscopic therapy - a retrospective evaluatioC15Malignant neoplasm of oesophagusDRKS00023947Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main80
进行中（未招募）
不适用
Primary Biliary Cirrhosis: Investigating A New Treatment Option using NI 0801, a fully human anti-CXCL10 monoclonal antibody.Proven PBC, as demonstrated by the presence of at least 2 of the following 3 diagnostic factors: - History of increased ALP levels for at least 6 months - Positive serum AMA titer (>1:40) - Liver biopsy consistent with PBC Patient should be on incomplete response to UDCAMedDRA version: 14.1Level: SOCClassification code 10021428Term: Immune system disordersSystem Organ Class: 10021428 - Immune system disordersMedDRA version: 14.1Level: SOCClassification code 10019805Term: Hepatobiliary disordersSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2011-001326-26-ITOVIMMUNE BV40
进行中（未招募）
不适用
Primary Biliary Cirrhosis: Investigating A New Treatment Option using NI-0801, a fully human anti-CXCL10 monoclonal antibody.Primary biliary cirrhosisMedDRA version: 14.1Level: LLTClassification code 10036680Term: Primary biliary cirrhosisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2011-001326-26-GBovImmune S.A.